OSR Holdings, Inc. (OSRH)
NCM – Real Time Price. Currency in USD
0.64
+0.07 (13.09%)
At close: May 12, 2026, 4:00 PM EDT
0.65
+0.01 (1.23%)
Pre-market: May 13, 2026, 4:52 AM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
0.64
+0.07 (13.09%)
At close: May 12, 2026, 4:00 PM EDT
0.65
+0.01 (1.23%)
Pre-market: May 13, 2026, 4:52 AM EDT
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
| Name | Position |
|---|---|
| Dr. Constance Hofer | Chief Scientific Officer |
| Mr. Chankyu Park | Chief Executive Officer of RMC |
| Mr. Gihyoun Bang | Chief Financial Officer |
| Mr. Jun Chul Whang | Chief Legal Officer, Secretary & Director |
| Mr. Kuk Hyoun Hwang | Chairman & CEO |
| Mr. Senyon Choe | Founder & CEO of Darnatein |
| Mr. Tim Smith | Corporate Secretary & Global IR |
| Mr. Yeiseok Kim | Chief Operating Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-11 | PRE 14A | ea0288424-01.htm |
| 2026-05-06 | 8-K/A | ea0289503-8ka1_osr.htm |
| 2026-04-30 | 8-K | ea0288465-8k_osrhold.htm |
| 2026-04-22 | 8-K | ea0287373-8k_osrhold.htm |
| 2026-04-09 | 8-K | ea0285550-8k_osr.htm |
| 2026-04-03 | 8-K/A | ea0285057-8ka1_osr.htm |
| 2026-04-02 | 8-K | ea0284791-8k_osr.htm |
| 2026-03-31 | 10-K | ea0283154-10k_osrhold.htm |
| 2026-03-16 | 8-K | ea0281786-8k_osr.htm |
| 2026-03-10 | 8-K | ea0280743-8k_osr.htm |